Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 20.10
+0.02 (0.10%)
Jul 29, 2026, 3:04 PM CST
SHE:300702 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 571.87 | 512.25 | 592.87 | 426.15 | 476.98 | 476.75 |
Trading Asset Securities | 0.63 | 0.8 | - | - | - | 72.94 |
Cash & Short-Term Investments | 572.5 | 513.05 | 592.87 | 426.15 | 476.98 | 549.7 |
Cash Growth | 4.35% | -13.46% | 39.12% | -10.66% | -13.23% | -58.80% |
Accounts Receivable | 536.37 | 719.17 | 594.26 | 583.07 | 455.15 | 489.08 |
Other Receivables | 173.52 | 2.26 | 1.98 | 5.01 | 6.4 | 6.22 |
Receivables | 709.89 | 721.43 | 596.24 | 588.09 | 461.56 | 495.3 |
Inventory | 1,594 | 1,714 | 1,881 | 1,890 | 2,017 | 1,599 |
Prepaid Expenses | - | - | 0.24 | - | - | - |
Other Current Assets | 44.2 | 63.92 | 59.15 | 47.38 | 61.95 | 188.71 |
Total Current Assets | 2,920 | 3,012 | 3,129 | 2,951 | 3,018 | 2,832 |
Property, Plant & Equipment | 2,868 | 2,916 | 2,821 | 2,793 | 2,810 | 2,465 |
Long-Term Investments | 103.61 | 99.71 | 88 | 89.85 | 87.57 | 78.61 |
Other Intangible Assets | 449.96 | 453.54 | 408.77 | 374.8 | 366.82 | 374.75 |
Long-Term Deferred Tax Assets | 11.77 | 13.68 | 15.08 | 8.25 | 15.86 | 15 |
Long-Term Deferred Charges | 39.11 | 43.19 | 61.35 | 77.57 | 60.54 | 3.55 |
Other Long-Term Assets | 47.86 | 51.02 | 54.89 | 43.38 | 57.27 | 31.49 |
Total Assets | 6,440 | 6,589 | 6,579 | 6,338 | 6,416 | 5,801 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 716.04 | 867.35 | 961.08 | 803.06 | 1,358 | 1,173 |
Accrued Expenses | 77.19 | 169.63 | 161.08 | 118.32 | 140.45 | 138.02 |
Short-Term Debt | 1,463 | 1,435 | 1,608 | 1,525 | 1,066 | 422.96 |
Current Portion of Long-Term Debt | 105.74 | 99.92 | 84 | 48.74 | 46.5 | 79.05 |
Current Portion of Leases | - | 8.26 | 9.44 | 8.96 | 9.29 | 14.27 |
Current Income Taxes Payable | 21.87 | 0.57 | 0.23 | 17.32 | - | - |
Current Unearned Revenue | 30.52 | 23.76 | 23.54 | 18.16 | 41.13 | 46.94 |
Other Current Liabilities | 41.48 | 21.22 | 16.16 | 23.78 | 8.59 | 3.56 |
Total Current Liabilities | 2,456 | 2,626 | 2,863 | 2,563 | 2,670 | 1,877 |
Long-Term Debt | 186.09 | 199.6 | 102.69 | 187.36 | 143.2 | 97.12 |
Long-Term Leases | 24.31 | 27.29 | 32.33 | 28.78 | 21.87 | 23.85 |
Long-Term Unearned Revenue | 66.28 | 66.64 | 67.95 | 64.41 | 69.19 | 70.92 |
Long-Term Deferred Tax Liabilities | 13.49 | 13.34 | 8.89 | 1.49 | 9.38 | 13.9 |
Other Long-Term Liabilities | 12.18 | 16.77 | 5.58 | 5.07 | 7 | 8.15 |
Total Liabilities | 2,758 | 2,950 | 3,081 | 2,850 | 2,921 | 2,091 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 347.98 | 347.98 | 347.98 | 347.98 | 347.98 | 347.98 |
Additional Paid-In Capital | 1,440 | 1,440 | 1,411 | 1,456 | 1,490 | 1,493 |
Retained Earnings | 1,945 | 1,903 | 1,781 | 1,742 | 1,715 | 1,869 |
Treasury Stock | -44.45 | -44.69 | -34.95 | -58 | -58 | - |
Comprehensive Income & Other | -6.66 | -6.66 | -6.66 | -0.14 | -0.14 | -0.14 |
Shareholders' Equity | 3,682 | 3,640 | 3,498 | 3,488 | 3,495 | 3,709 |
Total Liabilities & Equity | 6,440 | 6,589 | 6,579 | 6,338 | 6,416 | 5,801 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,779 | 1,770 | 1,836 | 1,799 | 1,287 | 637.26 |
Net Cash (Debt) | -1,207 | -1,257 | -1,243 | -1,373 | -810.23 | -87.56 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.54 | -3.69 | -3.56 | -4.01 | -2.32 | -0.25 |
Filing Date Shares Outstanding | 348.11 | 310.99 | 343.93 | 343.93 | 347.98 | 347.98 |
Total Common Shares Outstanding | 348.11 | 310.99 | 343.93 | 345.57 | 347.98 | 347.98 |
Working Capital | 464.37 | 386.02 | 265.8 | 388.06 | 347.65 | 954.76 |
Book Value Per Share | 10.58 | 11.70 | 10.17 | 10.09 | 10.04 | 10.66 |
Tangible Book Value | 3,232 | 3,186 | 3,089 | 3,113 | 3,128 | 3,334 |
Tangible Book Value Per Share | 9.28 | 10.24 | 8.98 | 9.01 | 8.99 | 9.58 |
Buildings | - | 1,349 | 1,118 | 1,056 | 1,000 | 798.58 |
Machinery | - | 3,105 | 2,873 | 2,646 | 2,316 | 1,831 |
Construction In Progress | - | 219.81 | 327.76 | 298.59 | 439.07 | 556.36 |